Marco Risso

2.4k total citations · 1 hit paper
41 papers, 1.8k citations indexed

About

Marco Risso is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Marco Risso has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 11 papers in Genetics and 11 papers in Oncology. Recurrent topics in Marco Risso's work include Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (9 papers) and Acute Lymphoblastic Leukemia research (7 papers). Marco Risso is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (9 papers) and Acute Lymphoblastic Leukemia research (7 papers). Marco Risso collaborates with scholars based in Italy, Iran and United Kingdom. Marco Risso's co-authors include Vito Pistoia, Francesca Gualandi, Gianluigi Mancardi, Federica Benvenuto, Elisa Ferretti, Debora Giunti, Anna Corcione, Antonio Uccelli, R Cerri and Andrea Bacigalupo and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer.

In The Last Decade

Marco Risso

41 papers receiving 1.7k citations

Hit Papers

Human mesenchymal stem cells modulate B-cell functions 2005 2026 2012 2019 2005 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Risso Italy 13 1.3k 478 435 421 349 41 1.8k
R. Laylor United Kingdom 8 1.2k 0.9× 605 1.3× 338 0.8× 324 0.8× 393 1.1× 11 1.7k
Steve Devine United States 13 1.7k 1.3× 738 1.5× 481 1.1× 516 1.2× 325 0.9× 22 2.3k
Inês Soeiro United Kingdom 11 1.1k 0.9× 414 0.9× 646 1.5× 284 0.7× 332 1.0× 12 1.8k
Ellie G.A. Lurvink Netherlands 7 1.0k 0.8× 449 0.9× 330 0.8× 350 0.8× 513 1.5× 9 1.5k
Sandrine Bouchet France 16 994 0.8× 451 0.9× 448 1.0× 246 0.6× 292 0.8× 31 1.7k
Christelle Mazurier France 14 1.4k 1.1× 685 1.4× 713 1.6× 363 0.9× 271 0.8× 26 2.2k
Katarina LeBlanc Sweden 16 1.0k 0.8× 471 1.0× 380 0.9× 339 0.8× 229 0.7× 21 1.6k
Frederik Wein Germany 14 1.5k 1.2× 622 1.3× 620 1.4× 449 1.1× 307 0.9× 20 2.1k
María L. Lamana Spain 15 863 0.7× 410 0.9× 383 0.9× 345 0.8× 207 0.6× 27 1.4k
Iekuni Oh Japan 15 852 0.7× 630 1.3× 434 1.0× 411 1.0× 364 1.0× 58 1.8k

Countries citing papers authored by Marco Risso

Since Specialization
Citations

This map shows the geographic impact of Marco Risso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Risso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Risso more than expected).

Fields of papers citing papers by Marco Risso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Risso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Risso. The network helps show where Marco Risso may publish in the future.

Co-authorship network of co-authors of Marco Risso

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Risso. A scholar is included among the top collaborators of Marco Risso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Risso. Marco Risso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giardino, Stefano, Arnoldo Piccardo, Massimo Conte, et al.. (2020). 131I‐Meta‐iodobenzylguanidine followed by busulfan and melphalan and autologous stem cell rescue in high‐risk neuroblastoma. Pediatric Blood & Cancer. 68(2). e28775–e28775. 5 indexed citations
2.
Micalizzi, Concetta, Thea Giacomini, Matteo Gastaldi, et al.. (2019). Bortezomib-Responsive Refractory Anti-N-Methyl-d-Aspartate Receptor Encephalitis. Pediatric Neurology. 103. 61–64. 24 indexed citations
3.
Prigione, Ignazia, Angela Elvira Covone, Francesca Giacopelli, et al.. (2015). IL12RB2 Polymorphisms correlate with risk of lung adenocarcinoma. Immunobiology. 221(2). 291–299. 5 indexed citations
4.
Ghio, Massimo, Paola Contini, Filippo Ansaldi, et al.. (2014). Immunomodulation due to plasma or plasma–platelet apheresis donation: Events occurring during donation procedures. Journal of Clinical Apheresis. 30(4). 204–211. 4 indexed citations
5.
Olivieri, Jacopo, Luca Pierelli, Martino Introna, et al.. (2013). Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey. Cytotherapy. 16(1). 101–110. 3 indexed citations
8.
Pira, Giuseppina Li, Federico Ivaldi, Paolo Moretti, et al.. (2010). Validation of a miniaturized assay based on IFNg secretion for assessment of specific T cell immunity. Journal of Immunological Methods. 355(1-2). 68–75. 6 indexed citations
9.
Pavesi, Elisa, Irma Dianzani, Giuseppe Santamaria, et al.. (2008). NOLA1 gene mutations in acquired aplastic anemia. Pediatric Blood & Cancer. 52(3). 376–378. 5 indexed citations
10.
Lamparelli, Teresa, Francesca Gualandi, D Occhini, et al.. (2007). Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant. Bone Marrow Transplantation. 40(4). 349–354. 14 indexed citations
12.
Pira, Giuseppina Li, et al.. (2006). A sealed and unbreached system for purification, stimulation, and expansion of cytomegalovirus‐specific human CD4 and CD8 T lymphocytes. Transfusion. 46(12). 2053–2062. 4 indexed citations
13.
Corcione, Anna, Federica Benvenuto, Elisa Ferretti, et al.. (2005). Human mesenchymal stem cells modulate B-cell functions. Blood. 107(1). 367–372. 1377 indexed citations breakdown →
14.
Damasio, E, Marino Clavio, Mauro Spriano, et al.. (2000). Alpha‐interferon as induction and maintenance therapy in hairy cell leukemia:a long‐term follow‐up analysis. European Journal Of Haematology. 64(1). 47–52. 20 indexed citations
15.
Carella, Angelo Michele, S Nati, P. Carlier, et al.. (1991). Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First Remission. Leukemia & lymphoma. 5(1). 43–47. 3 indexed citations
16.
Carella, Angelo Michele, S Nati, Gino Santini, et al.. (1990). A New Combination of Idarubicin, Etoposide and Cytarabine in Untreated Acute Non-Lymphoblastic Leukemia. Leukemia & lymphoma. 2(5). 317–322. 3 indexed citations
17.
18.
Carella, Angelo Michele, Gino Santini, Domenico Giordano, et al.. (1985). 4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study. Cancer. 55(7). 1452–1454. 52 indexed citations
19.
Am, Carella, Gino Santini, Francesco Frassoni, et al.. (1984). [Autologous bone marrow transplantation without cryopreservation after megadoses of oncolytic chemotherapy. Pilot study in 18 cases].. PubMed. 68(5). 620–37. 1 indexed citations
20.
Bacigalupo, Andrea, Marina Podestà, Francesco Frassoni, et al.. (1981). A monoclonal antibody to antigens expressed on MLR-activated T cells inhibits granulocyte macrophage colony formation.. The Journal of Immunology. 127(6). 2415–2417. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026